Advocacy materials

Monitoring fever treatment behaviour and equitable access to effective medicines in the context of initiatives to improve ACT access: baseline results and implications for programming in six African countries - Journal Article

Peer-reviewed | Benin | DR Congo | Madagascar | Nigeria | Uganda | Zambia | 2011

Littrell et al.: Monitoring fever treatment behaviour and equitable access to effective medicines in the context of initiatives to improve ACT access: baseline results and implications for programming in six African countries. Malaria Journal 2011 10:327.

Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria- endemic countries - Journal Article

Peer-reviewed | Benin | DR Congo | Madagascar | Nigeria | Uganda | Zambia | 2011

O’Connell et al.: Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries. Malaria Journal 2011 10:326.

The potential of the private sector to promote the integration of rapid diagnostic tests for malaria into developing country health systems: a multi-country study - Presentation

Presentations | Benin | DR Congo | Madagascar | Nigeria | Uganda | Zambia | 2011

Presented in July 2011 at the iHEA conference. 

The private sector role in the supply of antimalarial drugs: Evidence from ACTwatch & implications for initiatives to improve ACT access - Presentation

Presentations | Benin | Cambodia | DR Congo | Madagascar | Nigeria | Uganda | Zambia | 2011

Presented in July 2011 at the iHEA conference. 

Monitoring supply and demand for antimalarials and RDTs: an update on ACTwatch

Presentations | Benin | Cambodia | DR Congo | Kenya | Madagascar | Nigeria | Tanzania | Uganda | Zambia | 2013

Presented by Stephen Poyer on behalf of the ACTwatch group at the 6th Pan-African Malaria Conference (MIM 2013) in Durban in October 2013. 

Trends in Antimalarial Drug Use in Africa

Peer-reviewed | Benin | DR Congo | Kenya | Madagascar | Nigeria | Tanzania | Uganda | Zambia | 2013

Flegg J.A. et al., Am. J. Trop. Med. Hyg., 89(5), 2013, pp. 857865 doi:10.4269/ajtmh.13-0129

Methods for implementing a medicine outlet survey: lessons from the anti-malarial market

Peer-reviewed | Benin | Cambodia | DR Congo | Kenya | Madagascar | Myanmar | Nigeria | Tanzania | Uganda | Zambia | 2013

O’Connell et al., Malaria Journal 2013, 12:52 http://www.malariajournal.com/content/12/1/52

ACTwatch Outlet Surveys 2013‐2014 ORS and Zinc Availability Findings from 9 Countries

Multi-country | Benin | Cambodia | DR Congo | Kenya | Madagascar | Nigeria | Tanzania | Uganda | Zambia | 2015

ACTwatch antimalarial medicine outlet surveys were conducted in 2013 in the DRC (Kinshasa & Katanga provinces), Cambodia, Madagascar, Nigeria, and Uganda, and in 2014 in Benin, Kenya, Tanzania and Zambia. A representative sample of clusters was selected to provide national estimates (provincial estimates only in the DRC) as well as estimates in urban and rural areas in Benin, DRC, Kenya, Madagascar, Tanzania, Uganda and Zambia. Within selected clusters, a census of all outlets with the potential to sell or distribute antimalarials and/or provide malaria blood testing was completed. All enumerated outlets were administered a series of screening questions to assess eligibility of the ACTwatch outlet survey. Screened outlets were administered additional questions to assess availability of ORS and zinc. This document summarizes the findings from these ORS and zinc availability questions. 

Malaria market trends in Sub-Saharan Africa: 2009-2014

Multi-country | Benin | DR Congo | Kenya | Madagascar | Myanmar | Nigeria | Tanzania | Uganda | Zambia | 2015

This report highlights key trends and most recent findings regarding antimalarial markets across 8 of the ACTwatch sub-Saharan African  countries.  

Pages